Todd Walker is the Executive Director and Chief Strategist at HedgeTracker, where he is responsible for overseeing research, analytics and business development. He has particular expertise in investments that are popular among elite hedge fund managers, shareholder activists and green/sustainability-oriented investors. Prior to joining HedgeTracker in 2003, Mr. Walker headed up a hedge fund research team at a Fortune 1000 financial firm.
I am both a short term trader and a long term investor involved in the Forex market and stocks.
Approximately 70% of my portfolio is on long term investment vehicles like stocks, while the remaining 30% is in Forex, CFDs and Binary Options, 10% each.
As such am both long/short equity in most cases, but my disclosures are usually based on the long-term holdings.
Therefore, sometimes when I say I have no position held in a particular stock, that does not mean that I won't be trading it via CFDs if available within the next few days.
I was a register rep in 1964, eventually I became a put and call options broker before they were listed, I created and took several companies public and now travel the world constantly and thru the Internet and IBD search out and speculate in small cap company's stocks. I will occasionally buy micro cap or bigger types
6 years in investment banking at Bulge bracket, 2 years at Italian Bank, 1.5 year at Hedge Fund
Engineer, MBA, CFA Charterholder
10 years total in Financial markets
Currently managing personal assets: mainly biotech, banks, value stocks, event situations
Small-Cap PM and Analyst. I love to be first at bat, hitting the micro/small cap stock home-runs. I'm a portfolio builder and stock picker w/o the fluff, one who likes to avoid the crowds and the stock of the day. I'm not a stock collector (market dynamics have changed, love affairs with stocks are so yesterday)--today, a buy and hold strategy must come with an expiration date. I'm forever a thematic player; I carve out positions with an eye on tomorrow's horizon--what technology or medical break-through is going to define a sector over time. The merits of my investment selection is proven worthy only if other investors (horses) eventually follow my lead and find my watering hole.
At Investment Underground, our editors are disciplined, independent journalists who dig into technology, commodities, and stock market news to break the stories that matter. Our active approach to journalism spans analysis and interviews with noteworthy leaders to uncover real news that affects business right now.
Most notably, our insights predicted the departure of Avon CEO, Andrea Jung, and Warren Buffett’s purchase of his first technology stock in over forty years at Berkshire Hathaway.
Our work appears in Google News, Seeking Alpha, Motley Fool, Morningstar, Vatalyst, Value Walk, and Guru Focus, among others.
Jay Singh is a finance enthusiast. Reading and blogging about finance in general and hedge funds in particular is both a passion and a professional way to find opportunities.
Currently, Jay mainly advises on global private equity but previously managed publicly-traded instruments both for institutions and family offices for over a decade. Hand in hand with global finance, he is also an active participant in technology start ups.
StockRiters is a boutique financial research firm that is trying hard to remove the word "boutique" from its list of adjectives. We have a diverse team of financial analysts, with a minimum qualification of an MBA, and we are trying very, very hard to diversify further. Right now, we cover biotech, semiconductors, energy, telecom, mining, an occasional emerging company that we think has value. We also like writing on dividends, mREITs, Chinese and Indian ADRs, and gold.
Contact us at email@example.com if you need financial research, be it for a website, or for a fund manager, or even for a private investor.
My firm counsels investor relations departments of public companies around the world on how to use web technologies to communicate with investors, analysts and investment bloggers. Our research and guidelines have been cited and referenced by industry associations, academics and consultants around the world. I have been quoted by many financial publications on the topic of investor-centric online investor relations communications, including Bloomberg, The Wall Street Journal, Investor Relations Magazine, Real IR, NIRI’s IR Update; CFO magazine, Investor Relations Business, Investor Relations Newsletter, Corporate Governance Advisor, The Globe and Mail Report on Business, Financial Executive, and the National Post.
If you have any input to share on how companies can improve their online IR practices, please share them via SA mail.
Editor and Publisher ... Henry enters his thirteen (13) year at RegMed Investors which aggregates, curates and creates bottom-line content of regenerative medicine - stem, gene and cell therapy news providing a "vetted" selection of relevant and high-impact synthesis.
He was VP - Strategic Planning and Communication at Curis (2001-2002), HQCM focusing on healthcare investments (NYSE:HQH/HQL) from (1985-2001)and founded LifeScience Economics, a healthcare research and analytics firm with offices in Boston, MA and Palo Alto, CA. Past experiences include Thermo Scientific, SWEC following 5 years at the FBI. A former military officer, Henry has been an adjunct professor at Boston University and Golden Gate University where he taught courses in venture capital, corporate finance and strategic development in the universities' graduate business schools.
Founded in 2008, we are the general partner of two private investment vehicles (closed to new investors) with a total of $83 million in assets under management. We are not an investment adviser; please do not contact us regarding investment advisory services. If you are an institutional investor who wishes to discuss a shared position, we welcome the opportunity.
The Business Insider (TBI) is a business site with deep financial, entertainment, green tech and digital industry verticals. The flagship vertical, Silicon Alley Insider, was launched on July 19, 2007, and led by DoubleClick founders Dwight Merriman and Kevin Ryan and former top-ranked Wall Street analyst Henry Blodget.
One year after launch, two more verticals joined Silicon Alley Insider. Clusterstock is a financial section led by Henry and John Carney, Founding Editor of Dealbreaker.com. The Biz (formerly The Business Sheet) is an entertainment/media-focused endeavor.
A year and a half later, the three sites have relaunched under one brand to focus on building the leading online business news site for the digital age. There are no subscription fees or production delays. The Business Insider is dedicated to aggregating, reporting and analyzing the top news stories across the web and delivering them to you at rapid-fire pace.
In January 2015, Steven launched the Uguisu Value letter. Published quarterly, each issue features one thoroughly researched Japanese smaller-cap equity write-up that has baseline 2x upside. With returns of 30%-plus (40%+ yen-denominated) in 2013 and 2014, Steven remains focused on smaller caps as he invests alongside subscribers and maintains a concentrated portfolio. For more details see: http://steventowns.com/uguisu-value-newsletter/
Steven is also the author of 'Investing in Japan: There is no stock market as undervalued and as misunderstood' (2012). 'Investing in Japan' fills the void of information about Japanese stocks, providing a comprehensive overview of the market, challenging conventional wisdom of Japan being on its last leg, and providing insightful discussion of many key aspects to investing in Japan, including the strategies of investment funds, leading hedge funds, idiosyncrasies of the market, returns on equity, shareholder rights, and more. See book detail page below or paste the following book link to Amazon in your browser: http://amzn.to/AENfeH
Editor for The Biotech Forum (www.biotechforumsa.com), the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade. For Free weekly investment reports on small, attractive biotech stocks just register at www.bretjenseninvests.com
Dave Burwell is a Vice President with The Howard Group, providing Corporate Communication and Capital Market services for micro & small-cap companies. Established in 1988, The Howard Group is a Corporate Communication and Capital Markets firm. We look at a lot of micro and small-cap companies but choose to align ourselves with a select few. Our focus is on the long-term as building a business and building a public market following is not a quick process. Our services are tailored to each company we represent as we do not abide by the theory that one size fits all.
Marc is a frequent contributor to Investment U and also The Oxford Club’s Income Specialist and Editor of The Oxford Income Letter. He is the author of the best seller "Get Rich with Dividends".
His investment career started out at the trading desk of Carlin Equities in San Francisco, CA, where he executed dozens of trades each day for his clients.
As a Senior Analyst with Avalon Research Group, his buy recommendation gained 17.8% versus the S&P 500′s 5.9%. While there, Marc started and headed the technical research products division, in addition to his fundamental duties.
Marc also looked at the market with a journalist’s skeptical eye as a columnist for The Street, where he broke several stories on companies in the biotech sector. His contrarian recommendations (including shorts) gained 12.6% annualized versus the S&P 500′s gain of 0.5%.
Along with Oxford Club publications, Marc has appeared on Fox Business, Bloomberg Radio, Yahoo! Finance and been published in the online version of The Wall Street Journal, The Street, U.S News and World Report and was featured on NPR’s “The Story.”
Disclaimer: Money Morning and Stansberry & Associates Investment Research are separate companies, and entirely distinct. Their only common thread is a shared parent company, Agora Inc. Agora Inc. was named in the suit by the SEC and was exonerated by the court, and thus dropped from the case. Stansberry & Associates was found civilly liable for a matter that dealt with one writer’s report on a company. The action was not a criminal matter. The case is still on appeal, and no final decision has been made.
Edward Graham is Senior Analyst/Consultant, previously responsible for all healthcare positions in the UBS U.S. Small Cap Funds. He has 13 years of buy-side experience in Healthcare with a specialty in Medical Devices and Biotech investing. While at UBS, he developed a unique biotech investment strategy that captured alpha and reduced event risk. The strategy involved buying a basket of small cap biotech stocks with strong cash positions, diverse pipelines, and solid management teams.
Edward is dedicated to growth investing with expertise as a partner for an independent asset management boutique and as an investment team member for a multinational financial institution. Unique accomplishments include driving the growth of a start-up investment firm from $250M to $2B in AUM.
Eric Falkenstein (http://www.efalken.com) works for Walleye Software, based in Minneapolis. His blog, Falkenblog (http://falkenblog.blogspot.com/), is mainly about economics and finance. Prior published articles are kept here (http://www.efalken.com/papers/index.html).
Prior to his current position, Eric was a long/short equity portfolio manager at Deephaven Capital Management and Telluride Capital Management. Prior to that, at Moody's he developed RiskCalcTM, the leading tool for estimating private firm default risk. At KeyCorp bank, he was Head of Capital Allocations and Quantitative Research, and implemented various capital allocation processes around the bank. He has a PhD in economics from Northwestern University. His recent book, Finding Alpha, was published by Wiley Finance.
Visit his blog: Falkenblog (http://falkenblog.blogspot.com/)
Dr. John Hussman is the president and principal shareholder of Hussman Econometrics Advisors, the investment advisory firm that manages the Hussman Funds ( http://www.hussmanfunds.com). He holds a Ph.D. in economics from Stanford University, and a Masters degree in education and social policy and a bachelors degree in economics from Northwestern University. Prior to managing the Hussman Funds, Dr. Hussman was a professor of economics and international finance at the University of Michigan. In the mid-1980's, Dr Hussman worked as an options mathematician for Peters & Company at the Chicago Board of Trade, and in 1988 began publishing the Hussman Econometrics newsletter. Virtually all of Dr. Hussman's liquid assets are invested in the Hussman Funds.
Note: Dr. Hussman is not an active contributor to Seeking Alpha; rather, SA editors excerpt regularly from Dr. Hussman's public commentary.
I'm working as a consultant for the Chinese companies in their deals with Private Equity Firms.
I'm considered as a pattern day trader. I have been actively managing my personal portfolio since 2007. My trading strategies stemmed from my researches and my dissertations on Behavioral Finance as a Ph.D. student at Dept. of Economics at Rutgers. I believe in the EMH in the long run. However, the market tends to overreact due to its incompleteness and irrational participants.
My primary field of concentration was Financial Economics, with a secondary in Econometrics. I was qualified in Financial Economics at Princeton University through the Princeton-Rutgers Exchange Program. Prior to that, I was a bunker fuel oil broker in charge of the Great China regions and traveled extensively into the regions.
Green Chip Review is a biweekly newsletter focused helping investors profit from the development of cleantech and organic food markets. Covering policy, finance, technology and public markets, Green Chip takes a global soup-to-nuts approach in helping investors understand - and invest in - this still nascent but increasingly valuable market.
Mr. Butic is the owner and founder of Trout Payment Systems, a Houston based merchant services firm. His company sets businesses up to take electronic payments such as debit cards and credit cards or works with firms to find better payment providers.
Prior to Trout, Mr. Butic traded equities, options, and futures in his individual account full time and continues to follow the markets.
He was a Director at HedgeFund.net, a subsidiary of Guggenheim Partners, where he worked from June 2000 through August 2010. He ran the company's Manager Services Group which covered sales and recruitment activities for 7,000+ hedge fund products.
He graduated from the University of Texas at Austin in 2000 with a BBA, majored in finance and minored in philosophy.
Old Trader is a 63 year old private investor, managing a retirement portfolio constructed to a) generate a high current yield, b) preserve capital, and c) increase capital. His methodology involves taking a "top down" macro view to identify favorable trends, and then engage in fundamental analysis at the company level to identify "best of breed" companies that will benefit from those trends. He employs some simple TA to help determine favorable entry and exit points for positions.
The ultimate goal is the construction of an "absolute return" portfolio, fully recognizing that such a portfolio will lag in a strong bull market, but will result in much smoother returns, a characteristic he feels is critical for retirement accounts.
Founder and moderator of Chicagoland Investors' Group. Monthly Sunday brunch meetings to discuss markets and investing/trading strategies.
I can be reached at firstname.lastname@example.org
Anthony J. Alfidi is the founder and CEO of Alfidi Capital, a private research firm in San Francisco, California. Alfidi Capital publishes free financial research with honesty and humor.
Mr. Alfidi holds a Bachelor's degree in human resource management from the University of Notre Dame (cum laude) and an MBA in finance from the University of San Francisco. He is a life member of Beta Gamma Sigma, the academic honor society for business majors. He has been a private investor since the 1990s.
Maz Jadallah is the founder of AlphaClone, a technology-driven investment management firm where he serves as CEO and Portfolio Manager. Prior to founding AlphaClone, Maz spent 12 years in senior financial analyst, strategy and technology management roles. Most recently Maz was SVP of Corporate Development at Nasdaq-traded OpenTV. Prior to that, Maz worked at Time Warner Inc where amongst other roles he served as Senior Director reporting directly to Richard Parsons, the then co-COO. Maz is a life long investor, a registered investment advisor representative and has a Series 65 license. He holds an MBA with honors in Finance and Management from Rollins College and a BS in Industrial Engineering from Texas Tech University.
I am the Founder and CEO of Hedgeable. Hedgeable is a next generation investing brand revolutionizing the retirement market.
My market commentary has been featured in such places as MarketWatch, CNN Money, Forbes, Yahoo, the AP, The Washington Post, ABC News, and the Boston Globe. Hedgeable has been featured in Bloomberg BusinessWeek, Barron's, The Economist, SmartMoney,The New York Times, Reuters, American Banker, Financial Planning, and Wall Street & Technology.
I was formerly at Spruce Private Investors, a $3.0 billion money manager, named in 2011 by Private Asset Management Magazine as the top wealth manager in the United States. Prior to that I was at Bridgewater Associates, an $80 billion global macro hedge fund.
I can be reached at email@example.com.